253 related articles for article (PubMed ID: 34158591)
1. The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response.
Wang G; Xu D; Zhang Z; Li X; Shi J; Sun J; Liu HZ; Li X; Zhou M; Zheng T
NPJ Precis Oncol; 2021 Jun; 5(1):56. PubMed ID: 34158591
[TBL] [Abstract][Full Text] [Related]
2. Pan-sarcoma characterization of lncRNAs in the crosstalk of EMT and tumour immunity identifies distinct clinical outcomes and potential implications for immunotherapy.
Shi D; Mu S; Pu F; Zhong B; Hu B; Muhtar M; Tong W; Shao Z; Zhang Z; Liu J
Cell Mol Life Sci; 2022 Jul; 79(8):427. PubMed ID: 35842562
[TBL] [Abstract][Full Text] [Related]
3. Bidirectional crosstalk between epithelial-mesenchymal plasticity and IFN
Burger GA; Nesenberend DN; Lems CM; Hille SC; Beltman JB
R Soc Open Sci; 2022 Nov; 9(11):220186. PubMed ID: 36397970
[TBL] [Abstract][Full Text] [Related]
4. EMT-induced immune evasion: connecting the dots from mechanisms to therapy.
Imodoye SO; Adedokun KA
Clin Exp Med; 2023 Dec; 23(8):4265-4287. PubMed ID: 37966552
[TBL] [Abstract][Full Text] [Related]
5. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
6. Single-cell and multi-omics analyses highlight cancer-associated fibroblasts-induced immune evasion and epithelial mesenchymal transition for smoking bladder cancer.
Wu J; Gao F; Meng R; Li H; Mao Z; Xiao Y; Pu Q; Du M; Zhang Z; Shao Q; Zheng R; Wang M
Toxicology; 2024 May; 504():153782. PubMed ID: 38493947
[TBL] [Abstract][Full Text] [Related]
7. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion.
Jiang Y; Zhan H
Cancer Lett; 2020 Jan; 468():72-81. PubMed ID: 31605776
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1.
Hu B; Tian X; Li Y; Liu Y; Yang T; Han Z; An J; Kong L; Li Y
Cancer Med; 2020 Apr; 9(8):2686-2697. PubMed ID: 32077634
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between 5-methylcytosine and N
Tian Y; Xiao H; Yang Y; Zhang P; Yuan J; Zhang W; Chen L; Fan Y; Zhang J; Cheng H; Deng T; Yang L; Wang W; Chen G; Wang P; Gong P; Niu X; Zhang X
Mol Cancer; 2023 Jan; 22(1):5. PubMed ID: 36627693
[TBL] [Abstract][Full Text] [Related]
10. Do Tumor Mechanical Stresses Promote Cancer Immune Escape?
Onwudiwe K; Najera J; Siri S; Datta M
Cells; 2022 Nov; 11(23):. PubMed ID: 36497097
[TBL] [Abstract][Full Text] [Related]
11. The clinical relevance of epithelial-mesenchymal transition and its correlations with tumorigenic immune infiltrates in hepatocellular carcinoma.
Qiu ZQ; Wang X; Ji XW; Jiang FJ; Han XY; Zhang WL; An YH
Immunology; 2022 Jun; 166(2):185-196. PubMed ID: 35274290
[TBL] [Abstract][Full Text] [Related]
12. Multi-omics landscape analysis reveals the pan-cancer association of arginine biosynthesis genes with tumor immune evasion and therapy resistance.
Tan Z; Li H; Huang Y; Fu S; Wang H; Wang J
Heliyon; 2024 Mar; 10(5):e26804. PubMed ID: 38468956
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention.
Antony J; Thiery JP; Huang RY
Phys Biol; 2019 May; 16(4):041004. PubMed ID: 30939460
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion.
Mullins RDZ; Pal A; Barrett TF; Heft Neal ME; Puram SV
Cancer Res; 2022 Jul; 82(13):2329-2343. PubMed ID: 35363853
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas.
Gibbons DL; Creighton CJ
Dev Dyn; 2018 Mar; 247(3):555-564. PubMed ID: 28073171
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer quantitation of epithelial-mesenchymal transition dynamics using parallel reaction monitoring-based targeted proteomics approach.
Jain AP; Sambath J; Sathe G; George IA; Pandey A; Thompson EW; Kumar P
J Transl Med; 2022 Feb; 20(1):84. PubMed ID: 35148768
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics.
Chaves LP; Melo CM; Saggioro FP; Reis RBD; Squire JA
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946849
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung.
Kim S; Koh J; Kim MY; Kwon D; Go H; Kim YA; Jeon YK; Chung DH
Hum Pathol; 2016 Dec; 58():7-14. PubMed ID: 27473266
[TBL] [Abstract][Full Text] [Related]
19. ZEB1 transcription factor promotes immune escape in melanoma.
Plaschka M; Benboubker V; Grimont M; Berthet J; Tonon L; Lopez J; Le-Bouar M; Balme B; Tondeur G; de la Fouchardière A; Larue L; Puisieux A; Grinberg-Bleyer Y; Bendriss-Vermare N; Dubois B; Caux C; Dalle S; Caramel J
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288462
[TBL] [Abstract][Full Text] [Related]
20. Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial-Mesenchymal Transition Score in Prognosis Prediction.
Ko YC; Lai TY; Hsu SC; Wang FH; Su SY; Chen YL; Tsai ML; Wu CC; Hsiao JR; Chang JY; Wu YM; Robinson DR; Lin CY; Lin SF
Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32605311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
